Scientific Sessions 2025  /  Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis  /  The past, present, and future of antiplatelet therapy and prevention of thrombosis
Logo

American Heart Association

  20
  0

Final ID:

The past, present, and future of antiplatelet therapy and prevention of thrombosis

  • Holinstat, Michael  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Bergmeier, Wolfgang  ( UNIV NORTH CAROLINA , Chapel Hill , North Carolina , United States )
    • Author Disclosures:
    Michael Holinstat: DO have relevant financial relationships ; Consultant:Cereno Scientific:Active (exists now) ; Research Funding (PI or named investigator):Lexicon Pharmaceuticals:Past (completed) ; Royalties/Patent Beneficiary:Veralox Therapeutics:Active (exists now) ; Advisor:Veralox Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Cereno Scientific:Active (exists now) ; Royalties/Patent Beneficiary:Cereno Scientific:Active (exists now) | Wolfgang Bergmeier: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Development of phosphatidylserine-blocking nanoparticles to inhibit thrombosis

Goldfinger Lawrence, Rand Margaret

Oxylipin regulators of platelet function and thrombosis

Patrignani Paola, Hwa John

You have to be authorized to contact abstract author. Please, Login
Not Available